OSTEOPORE LIMITED — Capital/Financing Update 2020

Mar 9, 2020

==> picture [130 x 44] intentionally omitted <==

ASX RELEASE│OSTEOPORE LIMITED

10 March 2020

Company Announcements Office ASX Limited

By E-Lodgement

Notice of Release from Escrow

In accordance with ASX Listing Rule 3.10A, Osteopore Limited (ASX:OSX) advises that the following securities are due to be released from escrow on 18 March 2020 as follows:-

Security details	Number of securities
Fully paid ordinaryshares	5,439,213

The Company will seek quotation of 5,439,213 fully paid ordinary shares.

This release has been approved for release by Osteopore’s Board of Directors.

For more information please contact:

Deborah Ho

Company Secretary Osteopore Limited P: +61 8 9482 0500

About Osteopore Limited

Osteopore Limited is an Australian and Singapore based medical technology company commercialising a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. Osteopore's patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.

Osteopore's patent protected scaffolds are made from proprietary polymer formulations, that naturally dissolve overtime to leave only natural. healthy bone tissue, significantly reducing postsurgery complications that are commonly associated with permanent bone implants.

Osteopore Limited (ACN 630 538 957)│ASX:OSX│16 Ord Street, West Perth│+618 9482 0500│www.osteopore.com